Many at high cardiovascular risk still not on statins

Many at high cardiovascular risk still not on statins

(HealthDay)—Many individuals at high risk for cardiovascular events, such as those with coronary artery disease, diabetes, or both, are not receiving statins, according to research published in the May/June issue of the Annals of Family Medicine.

Michael Edward Johansen, M.D., of The Ohio State University in Columbus, and colleagues analyzed data for a nationally representative sample of 16,712 individuals in the United States, aged 30 to 79 years, to assess the association between statin use and cardiovascular risk. Those who reported filling two or more statin prescriptions were classified as statin users.

The researchers found that, overall, 58.2 percent of individuals with coronary artery disease (95 percent confidence interval [CI], 54.6 to 61.7 percent) and 52.0 percent of those with diabetes who were older than 40 years (95 percent CI, 49.4 to 54.6 percent) were statin users. After multivariable adjustment, the likelihood of being a statin user was significantly higher among individuals with both hyperlipidemia and coronary artery disease (odds ratio [OR], 0.44; 95 percent CI, 0.40 to 0.48) or hyperlipidemia only (OR, 0.32; 95 percent CI, 0.30 to 0.33) than among those with only (OR, 0.11; 95 percent CI, 0.07 to 0.15). A similar pattern was observed among individuals with diabetes.

"Recently released guidelines from the American College of Cardiology and the American Heart Association offer an opportunity to improve statin use by focusing on instead of lipid levels," the authors write.

More information: Abstract
Full Text

add to favorites email to friend print save as pdf

Related Stories

Interarm BP difference may up cardiac risk in diabetes

Apr 03, 2014

(HealthDay)—Interarm differences in systolic blood pressure (BP) in patients with diabetes may be associated with an increased risk of cardiovascular morbidity and mortality, according to research published ...

Clopidogrel after MI less effective in diabetes patients

Sep 05, 2012

(HealthDay)—Clopidogrel therapy following a heart attack does less to reduce the risk of death in patients with diabetes than in those without diabetes, according to a study published in the Sept. 5 issue ...

Recommended for you

ICD home monitoring cost compares, but reimbursement lags 

6 minutes ago

Roughly a decade since the start of telemonitoring capabilities in implantable cardiac defibrillators (ICDs), the first financial assessment of the impact of home monitored follow-up estimates the cost to physicians, hospitals ...

Biventricular pacing disappoints in BIOPACE trial 

16 minutes ago

Biventricular (BiV) pacing failed to significantly improve outcome compared to right ventricular (RV) pacing in patients with atrio-ventricular block (AVB) according to preliminary results presented as a Hot Line at ESC Congress ...

User comments